Prescribed board changes at Ascendis Health, which inject a strong dose of consumer sector expertise, proved to be just the tonic for the depressed health-care company on Friday. The debt-laden company’s share price shot up more than 12% following the appointment of two nonexecutive directors — Phil Roux, the former CEO of Pioneer Foods, and Andrew Marshall, who enjoyed successful stints as CEO at fishing group Oceana and packaging giant Nampak. Marshall replaces experienced nonexecutive chair John Bester, who retired. The changes headed off a tense showdown after a demand in late April by two significant shareholders — Mergence Investment Managers and Acanthin Capital — to convene a general meeting to nominate new nonexecutives to the board. The Ascendis share price, which had already shifted up on the recent sale of three bioscience businesses for R480m, closed at the weekend on an eight-week high of 505c after the board changes were confirmed early on Friday afternoon. The compan...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now